Taken together, these findings underscore the utility of Drosophila models in unraveling the complex molecular mechanisms involved in neurodegenerative diseases and identifying potential therapeutic targets that could alleviate pathology in patients with c9orf72-related ALS and FTD. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.